You are here

Article Text

Article menu
Download PDFPDF
Commentary
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers

https://doi.org/10.1136/ijgc-2022-003709

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • Twitter @DrRobDood

    • Contributors All authors provided: substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; participated in drafting the work or revising it critically for important intellectual content; gave final approval of the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

    • Funding RD was supported by the University of Utah WRHR from the National Institutes of Health K12HD085816, the Huntsman Cancer Foundation and the National Cancer Institute of the National Institutes of Health P30CA042014.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.